ConductScience.org, home

Paper36980210

Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer.

Huang PS and 7 others. Cells, 2023. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer. Papers, record 36980210. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980210

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer.
PubMed
Journal
Cells
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.9
iCite
Revised in PubMed
2024-09-15
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang PSPo-Shuan
2Wang LYLing-Yu
3Wang YWYi-Wen
4Tsai MMMing-Minghttps://orcid.org/0000-0002-4495-6616
5Lin TKTzu-Kang
6Liao CJChia-Jung
7Yeh CTChau-Ting
8Lin KHKwang-Hueihttps://orcid.org/0000-0002-5649-2222

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
alpha-FetoproteinsMajor topic
Liver NeoplasmsMajor topic
Humans
Early Detection of Cancer
Biomarkers
Drug Resistance

References195

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135223830The Roles of EphB2 in Cancer.Front Cell Dev Biol2022https://conductscience.org/library/papers/35223830PubMed
234282052Aberrant expression of WDR4 affects the clinical significance of cancer immunity in pan-cancer.Aging (Albany NY)2021https://conductscience.org/library/papers/34282052PubMed
334414118Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study.Liver Cancer2021https://conductscience.org/library/papers/34414118PubMed
432035242Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer.Gene2020https://conductscience.org/library/papers/32035242PubMed
518650514Sorafenib in advanced hepatocellular carcinoma.N Engl J Med2008https://conductscience.org/library/papers/18650514PubMed
632373951LncRNA NEAT1 regulates proliferation, apoptosis and invasion of liver cancer.Eur Rev Med Pharmacol Sci2020https://conductscience.org/library/papers/32373951PubMed
732782275Targeted therapy for hepatocellular carcinoma.Signal Transduct Target Ther2020https://conductscience.org/library/papers/32782275PubMed
833456577Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2.Theranostics2021https://conductscience.org/library/papers/33456577PubMed
925923690Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and the Risk of Head and Neck Cancer.PLoS One2015https://conductscience.org/library/papers/25923690PubMed
1033209421The impacts of ubiquilin 1 (UBQLN1) knockdown on cells viability, proliferation, and apoptosis are mediated by p53 in A549 lung cancer cells.J Thorac Dis2020https://conductscience.org/library/papers/33209421PubMed
1134658879YRDC Mediates the Resistance of Lenvatinib in Hepatocarcinoma Cells via Modulating the Translation of KRAS.Front Pharmacol2021https://conductscience.org/library/papers/34658879PubMed
1234914889Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.Lancet Oncol2022https://conductscience.org/library/papers/34914889PubMed
1331024205Hepatocellular Carcinoma: Etiology and Current and Future Drugs.J Clin Exp Hepatol2019https://conductscience.org/library/papers/31024205PubMed
1432506767MiR-145 in cancer therapy resistance and sensitivity: A comprehensive review.Cancer Sci2020https://conductscience.org/library/papers/32506767PubMed
1531038847Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinoma.Cancer Med2019https://conductscience.org/library/papers/31038847PubMed
1616357600EPHX1 polymorphisms and the risk of lung cancer: a HuGE review.Epidemiology2006https://conductscience.org/library/papers/16357600PubMed
1733823894Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/33823894PubMed
1830391438lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.Gene2019https://conductscience.org/library/papers/30391438PubMed
1932019286Activation of Tyrosine Metabolism in CD13+ Cancer Stem Cells Drives Relapse in Hepatocellular Carcinoma.Cancer Res Treat2020https://conductscience.org/library/papers/32019286PubMed
2035184646microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3.Bioengineered2022https://conductscience.org/library/papers/35184646PubMed

See all 195 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42294982Downregulation of GMPS inhibited the proliferation of hepatocellular cancer cells via the regulation of STAT3/c-Myc pathway.Eur J Histochem2026https://conductscience.org/library/papers/42294982PubMed
42210102CCNA2, MAD2L1, AURKA, and PTTG1 promote proliferation and migration in hepatocellular carcinoma.BMC Gastroenterol2026https://conductscience.org/library/papers/42210102PubMed
42048041Squalene attenuates doxorubicin resistance in hepatocellular carcinoma by targeting SIRT6 to inhibit ERK1 deacetylation.Mol Cell Biochem2026https://conductscience.org/library/papers/42048041PubMed
42014849γ-terpinene inhibits the progression of hepatocellular carcinoma by regulating the PTEN/PI3K/Akt signaling pathway mediated glycolysis.Sci Rep2026https://conductscience.org/library/papers/42014849PubMed
41972163CD24 as an innate immune checkpoint in solid tumors: biology, biomarker stratification, and therapeutic translation.Front Immunol2026https://conductscience.org/library/papers/41972163PubMed
41642374Combination of sodium pentaborate pentahydrate, curcumin and piperine treatment induces ferroptosis in hepatocellular carcinoma cells by regulating iron homeostasis and ROS activity in vitro.Med Oncol2026https://conductscience.org/library/papers/41642374PubMed
40347395The effect of continuous infusion chemotherapy through femoral artery catheterization on GP73, AFP-L3, and safety efficacy in liver cancer patients.Clin Exp Med2025https://conductscience.org/library/papers/40347395PubMed
40291897Novel multimodal analgesic regimen for perioperative pain management after hepatic artery infusion chemotherapy in patients with advanced hepatocellular carcinoma.World J Gastrointest Surg2025https://conductscience.org/library/papers/40291897PubMed
39822558Exploring potential key genes and pathways associatedwith hepatocellular carcinoma prognosis through bioinformatics analysis, followed by experimental validation.Am J Transl Res2024https://conductscience.org/library/papers/39822558PubMed
39816559Mitochondrial cholesterol metabolism related gene model predicts prognosis and treatment response in hepatocellular carcinoma.Transl Cancer Res2024https://conductscience.org/library/papers/39816559PubMed
39664575NR4A3 inhibits the tumor progression of hepatocellular carcinoma by inducing cell cycle G0/G1 phase arrest and upregulation of CDKN2AIP expression.Int J Biol Sci2024https://conductscience.org/library/papers/39664575PubMed
39105941
Cytoprotective effect of garlic alone versus co-administration of garlic and resveratrol in adriamycin-induced lung toxicity in albino rat: light microscopic, ultrastructural and immunohistochemical study.
J Mol Histol2024https://conductscience.org/library/papers/39105941PubMed
38997696Intricate effects of post-translational modifications in liver cancer: mechanisms to clinical applications.J Transl Med2024https://conductscience.org/library/papers/38997696PubMed
38737681Potential role of lncRNA LOXL1-AS1 in human cancer development: a narrative review.Transl Cancer Res2024https://conductscience.org/library/papers/38737681PubMed
38650929Ferroptosis in liver cancer: a key role of post-translational modifications.Front Immunol2024https://conductscience.org/library/papers/38650929PubMed

Download CSV of cited by

Genes128

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCG29429PubTator's text mininghttps://conductscience.org/library/genes/9429NCBI Gene
ACADL33PubTator's text mininghttps://conductscience.org/library/genes/33NCBI Gene
ACADM34PubTator's text mininghttps://conductscience.org/library/genes/34NCBI Gene
ACE1636PubTator's text mininghttps://conductscience.org/library/genes/1636NCBI Gene
ADA100PubTator's text mininghttps://conductscience.org/library/genes/100NCBI Gene
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
AGXT189PubTator's text mininghttps://conductscience.org/library/genes/189NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
AKT310000PubTator's text mininghttps://conductscience.org/library/genes/10000NCBI Gene
ANGPT2285PubTator's text mininghttps://conductscience.org/library/genes/285NCBI Gene
ANPEP290PubTator's text mininghttps://conductscience.org/library/genes/290NCBI Gene
ARID2196528PubTator's text mininghttps://conductscience.org/library/genes/196528NCBI Gene
ATG364422PubTator's text mininghttps://conductscience.org/library/genes/64422NCBI Gene
AXIN18312PubTator's text mininghttps://conductscience.org/library/genes/8312NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
CCNA2890PubTator's text mininghttps://conductscience.org/library/genes/890NCBI Gene
CCNB1891PubTator's text mininghttps://conductscience.org/library/genes/891NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
CD24100133941PubTator's text mininghttps://conductscience.org/library/genes/100133941NCBI Gene

See all 128 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36980210

GET https://conductscience.org/api/papers/v1/36980210/references?page=2